Filing Details
- Accession Number:
- 0001567619-22-007910
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-01 21:08:14
- Reporting Period:
- 2022-03-31
- Accepted Time:
- 2022-04-01 21:08:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1587221 | Zosano Pharma Corp | ZSAN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1145911 | J Donald Kellerman | C/O Zosano Pharma Corporation 34790 Ardentech Court Fremont CA 94555 | Vp, Clinical Dev & Med Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-03-31 | 4,006 | $0.21 | 56,331 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer.
Billionaire Hedge Funds
